Product image of Isopto Maxitrol (Neomycin Sulfate, Polymyxin B Sulfate, Dexamethasone) supplied by GNH India

Isopto Maxitrol

Active Ingredient:
Neomycin Sulfate, Polymyxin B Sulfate, Dexamethasone
Origin:
EU

Isopto Maxitrol (Neomycin Sulfate, Polymyxin B Sulfate, Dexamethasone)

Neomycin sulfate, Polymyxin B sulfate and Dexamethasone, the active ingredients in Isopto Maxitrol, are a combination antibiotic corticosteroid presented as an ophthalmic suspension for ocular use. It treats bacterial eye infections and associated inflammation in both adults and children as directed by a healthcare professional.

GNH India supplies Isopto Maxitrol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution and reliable service.

Manufacturer / TM Owner

Novartis Ireland Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Isopto Maxitrol, a combination antibiotic corticosteroid, acts on bacterial ocular infections and inflammatory processes.

  • Bacterial conjunctivitis: reduces bacterial load and alleviates associated redness and discharge.
  • Keratitis: treats corneal infection and helps control inflammation to preserve vision.
  • Ocular inflammation: diminishes swelling, pain and photophobia caused by inflammatory eye conditions.

How It Works

  • Neomycin sulfate interferes with bacterial protein synthesis by binding to the 30S ribosomal subunit, while Polymyxin B sulfate disrupts bacterial cell‑membrane integrity, leading to rapid bacterial death. Dexamethasone, a potent glucocorticoid, binds intracellular glucocorticoid receptors, modulating gene transcription to suppress pro‑inflammatory cytokines, reduce vascular permeability and inhibit leukocyte migration, thereby controlling ocular inflammation.

Side Effects

Adverse ocular reactions may occur with Isopto Maxitrol use.

Common Side Effects

  • Burning or stinging sensation upon instillation.
  • Temporary blurred vision.
  • Mild eye irritation or itching.
  • Redness of the conjunctiva.
  • Tearing or watery discharge.

Serious or Rare Side Effects

  • Increased intra‑ocular pressure leading to glaucoma.
  • Secondary ocular infection or fungal overgrowth.
  • Corneal ulceration or epithelial defect.
  • Allergic hypersensitivity reaction (e.g., rash, swelling).
  • Vision loss.

Precautions & Warnings

Before prescribing Isopto Maxitrol, consider the following precautions.

  • Pregnancy: safety not established; use only if potential benefit justifies risk.
  • Breastfeeding: unknown excretion; evaluate risk versus benefit.
  • Pre‑existing glaucoma or ocular hypertension: monitor intra‑ocular pressure closely.
  • Viral eye infections (e.g., herpes simplex): avoid as steroids may exacerbate infection.
  • Contact lens wearers: remove lenses before instillation and wait before reinserting.
  • Store at ambient temperature: keep in original container, protect from light and moisture.

Avoid Interactions

Isopto Maxitrol may interact with other ophthalmic or systemic agents.

Major Interactions (Avoid)

  • Systemic corticosteroids: additive immunosuppression may increase infection risk.
  • Other topical antibiotics: potential for antagonistic bacterial resistance.

Moderate Interactions (Monitor Closely)

  • Non‑steroidal anti‑inflammatory eye drops: may reduce steroid efficacy.
  • Anticholinergic eye medications: possible delayed wound healing.
  • Systemic aminoglycoside antibiotics: monitor for additive nephrotoxicity (though minimal ocular absorption).

Frequently Asked Questions

Isopto Maxitrol is a prescription ophthalmic suspension that combines the antibiotics neomycin sulfate and polymyxin B sulfate with the corticosteroid dexamethasone. It is indicated for the treatment of bacterial eye infections such as conjunctivitis and keratitis, and for reducing inflammation associated with these conditions.

Neomycin interferes with bacterial protein synthesis by binding the 30 S ribosomal subunit, while polymyxin B disrupts the bacterial cell‑membrane, causing rapid cell death. Dexamethasone activates glucocorticoid receptors, altering gene transcription to suppress inflammatory cytokines, reduce vascular leakage and limit leukocyte migration, thereby controlling ocular inflammation.

The dosing regimen for Isopto Maxitrol is determined by the prescribing clinician based on the severity of the infection, patient age and response to therapy. Typical instructions involve instilling one to two drops into the affected eye(s) at intervals specified by the healthcare professional.

Safety data for neomycin, polymyxin B and dexamethasone in pregnancy or lactation are limited. The product should be used only if the potential benefit outweighs any possible risk to the fetus or infant, and the decision should be made in consultation with a qualified healthcare provider.

To request Isopto Maxitrol, submit an enquiry on the product page at gnhindia.com, indicating the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with single‑agent antibiotic drops, Isopto Maxitrol offers both antibacterial activity (neomycin and polymyxin B) and anti‑inflammatory action (dexamethasone) in one formulation, which can simplify treatment regimens. However, clinicians may prefer separate agents when a steroid is contraindicated or when targeting specific bacterial spectra.

The suspension should be stored at room temperature, away from direct sunlight and moisture. Keep the vial tightly closed when not in use, and discard any remaining product after the labeled period after opening, as recommended by the manufacturer.

Isopto Maxitrol is applied as an eye drop. The patient should wash hands, tilt the head back, pull down the lower eyelid to form a pocket, and place the prescribed number of drops into the conjunctival sac. Contact lenses should be removed before instillation and re‑inserted after a suitable interval.

Serious adverse events can include a rise in intra‑ocular pressure leading to glaucoma, secondary ocular infections such as fungal overgrowth, corneal ulceration, and severe allergic reactions that may threaten vision. Any sudden vision changes or intense eye pain should prompt immediate medical evaluation.

Patients with known hypersensitivity to neomycin, polymyxin B, dexamethasone or any component of the formulation should avoid the product. It is also contraindicated in viral eye infections like herpes simplex keratitis, and should be used with caution in individuals with uncontrolled glaucoma or ocular hypertension.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.